These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19260092)

  • 1. Different estrogen sensitivity of urogenital tissue from women with and without stress urinary incontinence.
    Edwall L; Carlström K; Jonasson AF
    Neurourol Urodyn; 2009; 28(6):516-20. PubMed ID: 19260092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence.
    Edwall L; Carlström K; Jonasson AF
    Neurourol Urodyn; 2007; 26(3):410-5. PubMed ID: 17266139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence.
    Edwall L; Carlström K; Jonasson AF
    Neurourol Urodyn; 2005; 24(4):319-24. PubMed ID: 15924353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of estrogen receptor-alpha and -beta in the anterior vaginal wall of women with urinary incontinence.
    Xie Z; Shi H; Zhou C; Dong M; Hong L; Jin H
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):254-8. PubMed ID: 17287066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of estrogen and androgen levels after oral estrogen replacement therapy.
    Slater CC; Zhang C; Hodis HN; Mack WJ; Boostanfar R; Shoupe D; Paulson RJ; Stanczyk FZ
    J Reprod Med; 2001 Dec; 46(12):1052-6. PubMed ID: 11789085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
    O'Brien SN; Anandjiwala J; Price TM
    Obstet Gynecol; 1997 Aug; 90(2):244-8. PubMed ID: 9241302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic floor sex steroid hormone receptors, distribution and expression in pre- and postmenopausal stress urinary incontinent women.
    Söderberg MW; Johansson B; Masironi B; Byström B; Falconer C; Sahlin L; Ordeberg GE
    Acta Obstet Gynecol Scand; 2007; 86(11):1377-84. PubMed ID: 17963065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of collagen synthesis and degradation in urogenital tissue and serum from women with and without uterovaginal prolapse.
    Edwall L; Carlström K; Fianu Jonasson A
    Mol Hum Reprod; 2008 Mar; 14(3):193-7. PubMed ID: 18230625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrone - a partial estradiol antagonist in the normal breast.
    Lundström E; Conner P; Naessén S; Löfgren L; Carlström K; Söderqvist G
    Gynecol Endocrinol; 2015; 31(9):747-9. PubMed ID: 26190536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
    Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
    Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the extracellular matrix in periurethral tissue of women with stress urinary incontinence.
    Goepel C; Thomssen C
    Acta Histochem; 2006; 108(6):441-5. PubMed ID: 16962646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of hormones on urinary incontinence in postmenopausal women.
    Quinn SD; Domoney C
    Climacteric; 2009 Apr; 12(2):106-13. PubMed ID: 19259853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of collagen type VII in connective tissues of postmenopausal stress-incontinent women.
    Radziszewski P; Borkowski A; Torz C; Bossowska A; Gonkowski S; Majewski M
    Gynecol Endocrinol; 2005 Mar; 20(3):121-6. PubMed ID: 16019349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous estrogen and urinary incontinence.
    Jackson SL; Fihn SD
    J Urol; 2009 May; 181(5):1989-91. PubMed ID: 19286197
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of urinary incontinence in postmenopausal women].
    Semeniuk AA; Bitiukov NN; Krest'ianinov SS
    Urologiia; 2010; (6):34-6. PubMed ID: 21427991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.